🟢 Cue Biopharma is trading 6.2% up in pre-market

Cue Biopharma is trading at $20.78, up 6.18% in pre-market, with no confirmed company-specific catalyst identified.

• The move follows a 20.48% decline to $19.57 during the October 13 session.
• Positive CUE-221 Phase 2 results and B. Riley’s Buy initiation were reported earlier, but available sources do not link them directly to this move.
• Broader market gains were modest, and October 13 SEC filings disclosed proposed sales; neither has an established connection to the rebound.